Limiting molecular testing to people with thyroid nodules that are Bethesda category III or IV on repeat fine-needle aspiration, or FNA, cytology can reduce the rate of surgery of histologically benign nodules, according to study data.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.